Cresco Labs Inc. Stock News

The rescheduling of marijuana from a Schedule I to Schedule III drug in the United States would be transformative for the cannabis sector, CEOs of leading cannabis companies believe.  Last week, the

It seems that American marijuana stocks have an extremely powerful advocate. President Joe Biden was apparently behind a recent request to re-classify the drug.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk

Those looking for the best marijuana stocks to buy could be in luck. The level of volatile trading occurring in the market has led to a consistent decline in trading. Now most think when there is a dr

With a large amount of consistent success, more people are looking at the cannabis industry. Many want to know how they can get involved and make money. So there has been more attention surrounding ma

The U.S. Department of Health and Human Services just recommended easing regulations on marijuana. The U.S. Drug Enforcement Agency may (or may not) take that advice.

The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q

Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.05 per share a year ago.

The pot purveyor reported its second-quarter results. Yes, it booked a heavy net loss, but there were several positive developments during the period.

It's safe to say that a lot of the shine has worn off the top cannabis stocks in the past few years. The optimism that preceded legalization hasn't translated to strong businesses generally speaking.

Marijuana stock investors have been through a lot with the cannabis sector. Over the last 5 years much of the trading and investing that has occurred has changed. In 2018 the trading that happened was

In the dynamic landscape of the US cannabis industry, where the tide of legality has turned in favor of marijuana, investors find themselves at a pivotal juncture. As the cannabis sector readies to di

Cresco Labs and Columbia Care announced in March 2022 that they would be merging. Cannabis stocks have struggled mightily since then, however.

CHICAGO--(BUSINESS WIRE)--CRESCO LABS TO REPORT SECOND QUARTER 2023 FINANCIAL RESULTS ON AUGUST 16, 2023.